FI972415A0 - Käänteismiselli-(L2) tai normaalin misellirakenteen (L1) muodostava koostumus, josta vapautuminen on säädeltyä - Google Patents

Käänteismiselli-(L2) tai normaalin misellirakenteen (L1) muodostava koostumus, josta vapautuminen on säädeltyä

Info

Publication number
FI972415A0
FI972415A0 FI972415A FI972415A FI972415A0 FI 972415 A0 FI972415 A0 FI 972415A0 FI 972415 A FI972415 A FI 972415A FI 972415 A FI972415 A FI 972415A FI 972415 A0 FI972415 A0 FI 972415A0
Authority
FI
Finland
Prior art keywords
composition
pct
mixture
micelle
normal
Prior art date
Application number
FI972415A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI972415A (fi
Inventor
Kaore Larsson
Helena Ljusberg-Wahren
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Publication of FI972415A publication Critical patent/FI972415A/fi
Publication of FI972415A0 publication Critical patent/FI972415A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
FI972415A 1994-12-09 1997-06-06 Käänteismiselli-(L2) tai normaalin misellirakenteen (L1) muodostava koostumus, josta vapautuminen on säädeltyä FI972415A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9404289A SE518619C2 (sv) 1994-12-09 1994-12-09 Komposition för reglerad frisättning innehållande monokaproin
PCT/SE1995/001479 WO1996017597A1 (en) 1994-12-09 1995-12-08 Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure

Publications (2)

Publication Number Publication Date
FI972415A FI972415A (fi) 1997-06-06
FI972415A0 true FI972415A0 (fi) 1997-06-06

Family

ID=20396276

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972415A FI972415A0 (fi) 1994-12-09 1997-06-06 Käänteismiselli-(L2) tai normaalin misellirakenteen (L1) muodostava koostumus, josta vapautuminen on säädeltyä

Country Status (13)

Country Link
US (1) US5906831A (no)
EP (1) EP0790822B1 (no)
JP (1) JP3487860B2 (no)
AT (1) ATE213932T1 (no)
AU (1) AU4276896A (no)
BR (1) BR9509897A (no)
CA (1) CA2207218C (no)
DE (1) DE69525761T2 (no)
ES (1) ES2170171T3 (no)
FI (1) FI972415A0 (no)
NO (1) NO972614L (no)
SE (1) SE518619C2 (no)
WO (1) WO1996017597A1 (no)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US20020153508A1 (en) * 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
DE60221287T4 (de) * 2001-11-08 2009-06-25 Atrium Medical Corp. Intraluminale vorrichtung mit einer ein therapeutisches-mittel enthaltenden beschichtung
ATE424815T1 (de) * 2001-12-03 2009-03-15 Dor Biopharma Inc Stabilisierte umkehr-mizellen-zusammensetzungen und ihre verwendung
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2006036970A2 (en) * 2004-09-28 2006-04-06 Atrium Medical Corporation Method of thickening a coating using a drug
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
US8263102B2 (en) * 2004-09-28 2012-09-11 Atrium Medical Corporation Drug delivery coating for use with a stent
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US9801913B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Barrier layer
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
CA2626030A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
US7670997B2 (en) * 2006-06-08 2010-03-02 Bausch & Lomb Incorporated Ophthalmic compositions comprising a branched, glycerol monoalkyl compound and a fatty acid monoester
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
WO2008057328A2 (en) 2006-11-06 2008-05-15 Atrium Medical Corporation Tissue separating device with reinforced support for anchoring mechanisms
KR101522747B1 (ko) 2007-08-06 2015-05-26 알레간 인코포레이티드 데스모프레신 약물 전달을 위한 방법 및 장치
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
LT2712622T (lt) * 2008-05-21 2016-09-26 Ferring B.V. Burnoje disperguojamas desmopresinas, skirtas nikturijos netrikdomo miego pirminio periodo pailginimui
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
EP2593141B1 (en) 2010-07-16 2018-07-04 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
US9744542B2 (en) 2013-07-29 2017-08-29 Apeel Technology, Inc. Agricultural skin grafting
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
JP7157531B2 (ja) 2015-05-20 2022-10-20 アピール テクノロジー，インコーポレイテッド 植物抽出物組成物およびその調製方法
JP7049245B2 (ja) 2015-09-16 2022-04-06 アピール テクノロジー，インコーポレイテッド 分子コーティングのための前駆体化合物
WO2017100636A1 (en) 2015-12-10 2017-06-15 Apeel Technology, Inc. Plant extract compositions for forming protective coatings
TWI731928B (zh) 2016-01-26 2021-07-01 美商ａＰＥＥＬ科技公司 製備及保存經消毒產品之方法
EP3541192A4 (en) 2016-11-17 2020-07-01 Apeel Technology, Inc. COMPOSITIONS MOLDED FROM PLANT EXTRACTS AND METHOD FOR THE PRODUCTION THEREOF
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
JP2023516406A (ja) 2020-03-04 2023-04-19 アピール テクノロジー，インコーポレイテッド 被覆された農産物及び対応する方法
CN116457332A (zh) 2020-10-30 2023-07-18 阿比尔技术公司 组合物及其制备方法
WO2022098829A1 (en) * 2020-11-04 2022-05-12 Inolex Investment Corporation Biobased glyceryl heptanoate ester compositions and methods of making and using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
SE457693B (sv) * 1986-07-01 1989-01-23 Drilletten Ab Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas

Also Published As

Publication number Publication date
SE518619C2 (sv) 2002-10-29
DE69525761D1 (de) 2002-04-11
BR9509897A (pt) 1997-12-30
SE9404289D0 (sv) 1994-12-09
ES2170171T3 (es) 2002-08-01
ATE213932T1 (de) 2002-03-15
US5906831A (en) 1999-05-25
JP3487860B2 (ja) 2004-01-19
DE69525761T2 (de) 2002-10-24
CA2207218A1 (en) 1996-06-13
FI972415A (fi) 1997-06-06
AU4276896A (en) 1996-06-26
SE9404289L (sv) 1996-06-10
NO972614D0 (no) 1997-06-06
NO972614L (no) 1997-06-06
WO1996017597A1 (en) 1996-06-13
JPH10510260A (ja) 1998-10-06
CA2207218C (en) 2002-02-12
EP0790822B1 (en) 2002-03-06
EP0790822A1 (en) 1997-08-27

Similar Documents

Publication Publication Date Title
FI972415A0 (fi) Käänteismiselli-(L2) tai normaalin misellirakenteen (L1) muodostava koostumus, josta vapautuminen on säädeltyä
MX9200554A (es) Composicion analgesica topica y procedimiento para su preparacion
ATE169317T1 (de) Pyridobismidazole enthaltendes rigid-rod-polymer
BR9406823A (pt) Aminas secundárias e agentes anti-diabéticos e antiobesidade
PT81856B (pt) Processo para a preparacao de ingredientes activos a base de 3-(2,2-di-halogenovinil)2,2-dimetil-ciclopropano-carboxilatos de alfa-ciano-3-fenoxibenzilo e de composicoes insecticidas que os contem
ATE99924T1 (de) Amphipatische emulgiermittel enthaltende emulsionzusammensetzungen.
BRPI0409831A (pt) composição de condicionamento de tecidos, e, uso de um material não iÈnico
MX9500133A (es) Emulsiones de agua/aceite de alta fase interna.
EA200300630A1 (ru) Жидкая композиция для жарки
KR910019503A (ko) 수면 직접 시용(施用) 유성 현탁제제
HRP20060040A2 (en) PURE D-(17α)-13-ETHYL-17-HYDROXY-18,19-DINORPREGN-4-ENE-20-YNE-3-ONE-3E- AND -3Z-OXIME ISOMERS, AS WELL AS PROCESS FOR THE SYNTHESIS OF THE MIXTURE OF ISOMERS AND THE PURE ISOMERS
JPS568644A (en) Preparation of emulsified fat and oil product
KR890013166A (ko) 세제 조성물
KR910700043A (ko) 타정시에 있어서 응력분산 방법
KR920007538A (ko) 벤푸레세이트 및 다임론을 기재로 하는 제초 조성물
KR920021694A (ko) 친수성 무공해 광택제의 조성방법
RU92010882A (ru) Состав для разработки нефтяных месторождений
AR001341A1 (es) Composición coadyuvante líquida de uso agricola.
KR920011467A (ko) 치약 조성물
TH29574A (th) องค์ประกอบของสารทำความสะอาดที่มีฐานที่ปล่อยสารทำความสะอาด และสารที่ให้ประโยชน์แยกจากกันที่ฐานของสารให้ประโยชน์ประกอบด้วยสารลดแรงตึงผิว
TH23669B (th) องค์ประกอบของสารทำความสะอาดที่มีฐานที่ปล่อยสารทำความสะอาด และสารที่ให้ประโยชน์แยกจากกันที่ฐานของสารให้ประโยชน์ประกอบด้วยสารลดแรงตึงผิว
KR870008512A (ko) 식물 생장 조절용 조성물
KR950013492A (ko) 콜레스테릴 유도체가 함유된 마이크로에멀젼 조성물과 이를 이용한 반투명 화장료